S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Legendary Stockpicker: "Buy this A.I. stock NOW" (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Biden To Unleash "Choke Point" Operation On America? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Biden To Unleash "Choke Point" Operation On America? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Legendary Stockpicker: "Buy this A.I. stock NOW" (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Biden To Unleash "Choke Point" Operation On America? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Biden To Unleash "Choke Point" Operation On America? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Legendary Stockpicker: "Buy this A.I. stock NOW" (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Biden To Unleash "Choke Point" Operation On America? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Biden To Unleash "Choke Point" Operation On America? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Legendary Stockpicker: "Buy this A.I. stock NOW" (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Biden To Unleash "Choke Point" Operation On America? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Biden To Unleash "Choke Point" Operation On America? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
CVE:KHRN

Khiron Life Sciences (KHRN) Stock Forecast, Price & News

C$0.04
0.00 (0.00%)
(As of 09/16/2023)
Compare
Today's Range
C$0.04
▼
C$0.05
50-Day Range
C$0.04
▼
C$0.04
52-Week Range
C$0.04
▼
C$0.17
Volume
24,000 shs
Average Volume
256,268 shs
Market Capitalization
C$9.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlines

KHRN stock logo

About Khiron Life Sciences (CVE:KHRN) Stock

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

KHRN Price History

KHRN Stock News Headlines

May 24, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)
May 20, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp down on Monday (KHRN)
September 24, 2023 | Altimetry (Ad)
WARNING: Seven millionaires to trigger sudden market panic?
The next major selloff could be just days away…And seven powerful (yet completely unknown) insiders will be behind it all – and help corporate executives make a killing as it plays out. Here’s the full story.
May 4, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp WT down on Tuesday (KHRN-WT)
April 26, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp down on Tuesday (KHRN)
April 25, 2023 | msn.com
Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More
April 25, 2023 | finance.yahoo.com
Medical First: Germany Strengthens Reimbursement of Medical Cannabis
April 22, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp WT flat on Friday (KHRN-WT)
September 24, 2023 | Investor Place Media (Ad)
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
April 21, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp up on Thursday (KHRN)
April 21, 2023 | msn.com
Khiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS Subsidiary
April 20, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp WT flat on Tuesday (KHRN-WT)
April 15, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp flat on Friday (KHRN)
April 14, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp down on Wednesday (KHRN)
April 14, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp WT flat on Thursday (KHRN-WT)
April 7, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp WT flat on Wednesday (KHRN-WT)
April 4, 2023 | finance.yahoo.com
Khiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment Option
March 27, 2023 | finance.yahoo.com
KHIRON LIFE SCIENCES ANNOUNCES SIZING OF MARKETED OFFERING OF UNITS
March 13, 2023 | finance.yahoo.com
KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT MARKETED OFFERING
February 11, 2023 | theglobeandmail.com
Khiron Life Sciences: Stocks Overvalued by Analyst Consensus on TSX-V (KHRN)
January 19, 2023 | ca.finance.yahoo.com
Khiron begins dispensation of insurance-covered prescriptions in Colombia
January 19, 2023 | finanznachrichten.de
Khiron Life Sciences Corp.: Khiron begins dispensation of insurance-covered prescriptions in Colombia
January 16, 2023 | benzinga.com
NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patient
January 16, 2023 | finanznachrichten.de
Khiron Life Sciences Corp.: NHS reimburses the cost of cannabis treatment to the first Zerenia Clinics UK patient
January 5, 2023 | markets.businessinsider.com
Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products
November 30, 2022 | msn.com
Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
October 15, 2022 | uk.investing.com
Khiron Life Sciences Corp (4KH)
See More Headlines
Receive KHRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:KHRN
CUSIP
N/A
CIK
N/A
Web
www.khiron.ca
Phone
705-527-3564
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.17)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-30,660,000.00
Net Margins
-190.00%
Pretax Margin
N/A
Return on Equity
-74.68%
Return on Assets
-20.79%

Debt

Debt-to-Equity Ratio
9.46
Current Ratio
2.02
Quick Ratio
0.72

Sales & Book Value

Annual Sales
C$16.14 million
Price / Sales
0.58
Cash Flow
C$0.01 per share
Price / Cash Flow
6.67
Book Value
C$0.12 per share
Price / Book
0.33

Miscellaneous

Outstanding Shares
232,410,000
Free Float
N/A
Market Cap
C$9.30 million
Optionable
Not Optionable
Beta
3.16
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Alvaro Francisco Torres (Age 44)
    Co-Founder, CEO & Director
    Comp: $272.95k
  • Ms. Franziska Katterbach
    Pres of Khiron Europe
  • Mr. Swapan Kakumanu ACA (Age 53)
    ACWA, CGA, Corp. Sec.
    Comp: $60k
  • Mr. Michael John O'Connor MA (Age 56)
    Chief Financial Officer
  • Mr. Manuel Buendia
    VP of Operations
  • Mr. Marco Algorta
    Country Mang. of Uruguay

Key Competitors

View All Competitors













KHRN Stock - Frequently Asked Questions

How have KHRN shares performed in 2023?

Khiron Life Sciences' stock was trading at C$0.06 at the beginning of 2023. Since then, KHRN stock has decreased by 27.3% and is now trading at C$0.04.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Khiron Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Khiron Life Sciences investors own include Aurora Cannabis (ACB), Cross Timbers Royalty Trust (CRT), Curaleaf (CURLF), Walt Disney (DIS), Energy Transfer (ET), KushCo (KSHB), Neptune Wellness Solutions (NEPT), Organigram (OGI) and VIVO Cannabis (VVCIF).

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KHRN."

How do I buy shares of Khiron Life Sciences?

Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Khiron Life Sciences' stock price today?

One share of KHRN stock can currently be purchased for approximately C$0.04.

How much money does Khiron Life Sciences make?

Khiron Life Sciences (CVE:KHRN) has a market capitalization of C$9.30 million and generates C$16.14 million in revenue each year. The company earns C$-30,660,000.00 in net income (profit) each year or C($0.17) on an earnings per share basis.

How can I contact Khiron Life Sciences?

Khiron Life Sciences' mailing address is 500 Burrard Street, Suite 2300, Vancouver, BC V6C 2B5, Canada, . The official website for the company is www.khiron.ca. The company can be reached via phone at 705-527-3564.

This page (CVE:KHRN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -